baber/WOPTO huggingface dataset:
Patent IL-128619-A0 (IL)
Title: Polycarboxylic based cross-linked copolymers
IPC: C08B37/06
Filed: 1997-08-29
Abstract: The invention concerns cross-linked copolymers with a base of non cross-linked polycarboxylic polymers, said copolymers containing at least one polycarboxylic polysaccharide. The invention also concerns a method for preparing these copolymers and their use in particular as support in pharmaceutical compositions.
Patent IL-129532-A0 (IL)
Title: Polyolefins and their functionalized derivatives
IPC: C08F4/14
Filed: 1997-11-03
Abstract: PCT No. PCT/EP97/06068 Sec. 371 Date Jul. 27, 1999 Sec. 102(e) Date Jul. 27, 1999 PCT Filed Nov. 3, 1997 PCT Pub. No. WO98/20053 PCT Pub. Date May 14, 1998The present invention relates to at least simply unsaturated polyolefins with a number mean molecular weight in the range of 400 to 1,500 dalton and a dispersibility of MW/MN<1.2, obtained through catalytic dimerization from at least simply unsaturated olefin-oligomers, as well as to the method for their production. The present invention further relates to derivatives of these polyolefins which can be obtained by functionalizing at least a double link of the polyolefin. The invention also relates to the use of polyolefins and/or functionalization products as additives for fuels or lubricants.
Patent IL-131959-A0 (IL)
Title: Pharmaceutical combined preparations containing erythropoietin and iron preparations
IPC: A61K31/555
Filed: 1997-03-18
Abstract: A pharmaceutical composition comprising 250-20,000 U of an EPO preparation and 5-20 mg of a Fe(III) complex is disclosed. This pharmaceutical composition is useful in treating anaemias as well or as haemodialysis patients.
Patent IL-131984-A0 (IL)
Title: Security bar assembly
IPC: E06B9/06
Filed: 1998-03-18
Abstract: A security bar assembly has a plurality of bars that extend across an opening and have ends joined to drive chains to provide an easily removable assembly. The bars extend between two channels positioned on opposite faces of the opening, and are slidable within the channels. The ends of the bars are retained in the channels and the ends have connections to chain links in opposing drive chains which are spaced apart a predetermined number of links to keep the bars a predetermined distance apart. A drive mechanism is provided for moving the drive chains to slide the bars in the channels and a storage area adjacent the opening associated with the channels to retain the bars when they are not in place over the opening.
Patent IL-132440-A0 (IL)
Title: Low calorie palatable fiber-containing sugar substitute
IPC: A23G3/42
Filed: 1998-03-31
Abstract: This invention relates to a low calorie, palatable fiber-containing, sugar substitute composition suitable for use as a substitute for table sugar (for use on cereals, fruits, in hot or iced tea and coffee, etc.) and in the preparation of baked foods and other prepared solid and semi-solid foods.
Patent IL-144202-A0 (IL)
Title: Baff, related blocking agents and their use in the stimulation and inhibition of b-cells and immunoglobulins in immune responses
IPC: A61K39/395
Filed: 2000-01-25
Abstract: Stimulating B-cell growth, immunoglobulin production, or dendritic cell-induced B-cell growth and maturation, or co-stimulating B-cell growth and immunoglobulin production, comprising administering a composition containing the tumor necrosis factor family B cell activating factor (BAFF) or its active fragment, and optionally an anti-Micro antibody, a CD40 ligand or an anti-CD40 ligand, is new. An independent claim is also included for a method of inhibiting B-cell growth, immunoglobulin production, or dendritic cell-induced B-cell growth, or co-inhibiting B-cell growth and immunoglobulin production, comprising administering an anti-BAFF ligand molecule, a recombinant, inoperative BAFF ligand molecule, an antibody specific for BAFF ligand, active fragments of the molecules, or an antibody specific for BAFF ligand receptor, or an epitope of it. ACTIVITY : Immunosuppressive; virucide; antiinflammatory; hypotensive; nephrotropic; cardiant; cytostatic. No biological data is given. MECHANISM OF ACTION : B-cell growth and/or immunoglobulin production stimulators or inhibitors.
Patent IL-144745-A0 (IL)
Title: Quinazoline derivatives as angiogenesis inhibitors
IPC: A61P35/00
Filed: 2000-02-08
Abstract: The invention relates to the use of compounds of the formula I:   
wherein ring C is an 8, 9, 10, 12 or 13-membered bicyclic or tricyclic moiety which optionally may contain 1-3 heteroatoms selected independently from O, N and S; Z is -O-, -NH-, -S-, -CH 2 - or a direct bond; n is 0-5; m is 0-3; R 2  represents hydrogen, hydroxy, halogeno, cyano, nitro, trifluoromethyl, C 1-3 alkyl, C 1-3 alkoxy, C 1-3 alkylsulphanyl, -NR 3 R 4  (wherein R 3  and R 4 , which may be the same or different, each represents hydrogen or C 1-3 alkyl), or R 5 X 1 - (wherein X 1  and R 5  are as defined herein; R 1  represents hydrogen, oxo, halogeno, hydroxy, C 1-4 alkoxy, C 1-4 alkyl, C 1-4 alkoxymethyl, C 1-4 alkanoyl, C 1-4 haloalkyl, cyano, amino, C 2-5 alkenyl, C 2-5 alkynyl, C 1-3 alkanoyloxy, nitro, C 1-4 alkanoylamino, C 1-4 alkoxycarbonyl, C 1-4 alkylsulphanyl, C 1-4 alkylsulphinyl, C 1-4 alkylsulphonyl, carbamoyl,  N- C 1-4 alkylcarbamoyl,  N , N -di(C 1-4 alkyl)carbamoyl, aminosulphonyl,  N -C 1-4 alkylaminosulphonyl,  N , N -di(C 1-4 alkyl)ammosulphonyl,  N -(C 1-4 alkylsulphonyl)amino,  N- (C 1-4 alkylsulphonyl)- N -(C 1-4 alkyl)amino,  N , N -di(C 1-4 alkylsulphonyl)amino, a C 3-7 alkylene chain joined to two ring C carbon atoms, C 1-4 alkanoylaminoC 1-4 alkyl, carboxy or a group R 56 X 10  (wherein X 10  and R 56  are as defined herein); and salts thereof, in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals, processes for the preparation of such compounds, pharmaceutical compositions containing a compound of formula I or a pharmaceutically acceptable salt thereof as active ingredient and compounds of formula I. The compounds of formula I and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent IL-144768-A0 (IL)
Title: Network for telephony and data communication
IPC: H04B3/02
Filed: 2000-03-02
Abstract: A service outlet for coupling a data unit to a wired digital data signal and for coupling a service unit to an analog service signal, for use with a service wire pair installed in walls of a building, the service wire pair concurrently carrying a wired bi-directional digital data signal and an analog service signal carried over a service signal frequency band, using frequency division multiplexing, wherein the wired digital data signal is carried over a frequency band distinct from the service signal frequency band, wherein said service outlet comprises a single enclosure and, within said single enclosure: a wiring connector for connecting to the service wire pair, a first filter coupled to the wiring connector for passing only the analog service signal, a standard service connector coupled to the first filter and connectable to the service unit for coupling the service unit to the analog service signal, a second filter coupled to the wiring connector for passing only the wired digital data signal, a service wiring modem coupled to the second filter for coupling the second filter to the wired digital data signal, a standard data connector connectable to the data unit, a transceiver coupled to the standard data connector for coupling packet-based bi-directional digital data to the data unit, a multiport device consisting of one of a bridge, a router and a gateway coupled to said service wiring modem and said transceiver for coupling wired digital data contained in the wired digital data signal and the packet based digital data, and a power supply coupled to the service wiring modem and the transceiver for powering the service wiring modem and the transceiver.
Patent IL-146328-A0 (IL)
Title: Antiblock compositions and method of preparation
IPC: C09C1/30
Filed: 1999-12-22
Abstract: The present invention relates to a product, a process for its preparation and the use of such in plastic film production. More specifically, the present invention relates to an antiblock talc, a process for the preparation of such and its use as an additive in the production of polyolefin film. <??>Polyolefin films produced according to the process of the present invention are useful in a broad range of packaging and film covering applications.
Patent IL-146564-A0 (IL)
Title: Phenoxypropylamine derivatives and pharmaceutical compositions containing the same
IPC: C07D413/14
Filed: 2000-05-22
Abstract: The present invention relates to a phenoxypropylamine compound of the formula (I) <CHEM> wherein each symbol is as defined in the specification, an optically active compound thereof or a pharmaceutically acceptable salt thereof and hydrates thereof, which simultaneously show selective affinity for and antagonistic activity against 5-HT1A receptor, as well as 5-HT reuptake inhibitory activity, and can be used as antidepressants quick in expressing an anti-depressive effect.
Patent IL-152868-A0 (IL)
Title: NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11beta-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17alpha -METHOXYMETHYL-17beta-METHOXY-ESTRA-4,9-DIEN-3-ONE
IPC: A61K31/565
Filed: 2001-05-09
Abstract: Nonsolvated crystalline 11beta -(4-((E)-hydroxyiminomethyl)phenyl)-17alpha -methoxymethyl-17beta -methoxy-4,9-estradien-3-one (I) is new. An independent claim is also included for a process for preparing (I). ACTIVITY : Gynecological. MECHANISM OF ACTION : Progesterone receptor ligand.
Patent IL-174356-A0 (IL)
Title: High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
IPC: A61P29/00
Filed: 2006-03-16
Abstract: High-yield process for producing human antibodies (Ab) that neutralize the activity of one of the human cytokines (I) vascular endothelial growth factor (VEGF), interferonalpha (IFNa), interleukin-4 (IL4), tumor necrosis factoralpha (TNFa) and transforming growth factorbeta (TGFb), includes purification of immunoglobulins (Ig) present either in the serum or B cells of a subject who has been previously immunized against (I). ACTIVITY : Cytostatic; Immunostimulatory; Virucide; Antiinflammatory; Antiallergic; Immunosuppressive. No details of tests for these activities are given. MECHANISM OF ACTION : Inhibiting activity of specific cytokines.
Patent IL-187801-A0 (IL)
Title: A method of performing actions related to handover by a mobile station that is in power saving mode in a wireless mobile communication system
IPC: H04W36/36
Filed: 2007-12-02
Abstract: A method of performing actions related to handover by a mobile station (MS) in a wireless mobile communication system is disclosed. More specifically, the MS receives information from a base station (BS), wherein the information includes at least one action for performing handover and at least one condition corresponding to the at least one action. Furthermore, the MS transmits a request message to perform the at least one action based on the received information from the BS and receives a response message in response to the request message. Lastly, the MS performs the at least one action according to the received response message.
Patent IL-199302-A0 (IL)
Title: Method for the multipath passive radar processing of an fm opportunity signal
Filed: 2009-06-11
Abstract: A signal processing method performs operations of coherent processing making it possible notably to purge the useful signal of the spurious signals (in particular the reference signal and its multiple reflections), to regenerate the transmission signal and to perform a coherent integration of the signal received by computing the cross-ambiguity between the signal received and the regenerated transmission signal. It also performs operations of non-coherent processing making it possible in particular to carry out extraction and Doppler distance purification operations making it possible to form blips and to eliminate the spurious blips present among the blips formed. The method applies notably to passive radars operating on non-cooperating opportunity transmissions, such as FM transmissions intended for the public.
Patent RO-125165-A0 (RO)
Title: Obtaining ecological oil from grape seeds by extraction in microwave field
Inventor: PĂTRAŞCU MARIANA
IPC: C11B1/10
Filed: 2009-03-31
Abstract: The invention relates to a process for obtaining a grape seed oil. According to the invention, the process consists in extracting, in microwave field, the biological material consisting in grape seeds having a humidity of maximum 5% in a non-polar solvent chosen from among hexane, benzene, toluene, chloroform and dichloroethane, at the temperature of 50...70°C for 30...40 s, at a microwave maximum power of 500 W and at a frequency of 2450 MHz, afterwards the reaction product is cooled, in a controlled way, down to the temperature of 15...20°C, the operations being repeated 4 times, with successive heating and cooling, in order to obtain an oil content of maximum 7...9%.
Patent AP-2000001944-A0 (AP)
Title: Nonnucleoside inhibitors of reverse transcriptase for the treatment of HIV-infection.
Inventor: VIG RAKESH
IPC: C07D239/46
Filed: 1999-03-16
Abstract: Novel compounds that are potent inhibitors of hiv reverse transcriptase (rt)are described in the invention. These novel compounds also inhibit replication of a retrovirus, such as human immunodeficiency virus-1 (hiv-1). The novel compounds of the invention include analogs and derivatives of phenethylthiazolythiourea (pett), of dihydroalkoxybenzy-loxopyrimidine (dabo), and of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (hept). The invention additionally provides a composite hiv reverse-transcriptase (rt)nonnucleoside inhibitor (nni)binding pocket constructed from a composite of multiple nni-rt complexes. The composite rt-nni binding pocket provides a unique and useful tool for designing and identifying novel, potent inhibitors of reverse transcriptase.
Patent MW-2483-A1 (MW)
Title: Compositions
IPC: C06B45/00
Filed: 1983-06-10
Abstract: This invention concerns a water-in-oil emulsion explosive composition which comprises a discontinuous aqueous phase containing one or more oxygen-releasing salts, a continuous water-immiscible organic phase comprising sump oil, and an emulsifying agent. The explosive compositions show improved sensitivity over conventional compositions made using paraffin oil as the organic phase.
Patent IE-910457-A1 (IE)
Title: Lubricious hydrophilic coating, resistant to wet abrasion
Inventor: WHITBOURNE RICHARD J
IPC: C09D5/00
Filed: 1991-02-12
Abstract: The lubricious hydrophilic coatings of the invention are significantly more lubricious when wet than when dry, are adherent to a variety of substrates, and are resistant to removal by wet abrasion. In one embodiment, the coatings include a hydrophilic polyolefin such as polyvinyl-pyrrolidone and a waterinsoluble stabilizing polymer such as a cellulose ester. The coatings may also include an adherent polymer and a plasticizing agent. The coating may be applied by preparing a solution of the stabilizing polymer and a solution of the hydror/ ilic polyolefin, and coating the substrate first in one then the other. Alternatively, both the stabilizing and hydrophilic polymers may be dissolved in a single solvent system and applied to the substrate in a single step. In another embodiment, only a solution of a hydrophilic polyolefin is applied directly to the substrate. In this embodiment, the solution cf the hydrophilic polyolefin includes a cosolvent which acts as a solvent for both the hydrophilic polyolefin and the substrate. The coatings of the invention nay be applied to biomedical devices and implants such as catheters, condoms, and nasogastric and endotracheal tubes.
Patent MA-19434-A1 (MA)
Inventor: BARNES ALAN CHARLES
IPC: C07D471/04
Filed: 1982-04-02
Abstract: Novel imidazo[1,2-a]quinolines of the formula    <IMAGE>  I  wherein R is selected from the group consisting of alkyl of 1 to 8 carbon atoms, thienyl, pyridyl and phenyl optionally substituted with at least one member of the group consisting of halogen, alkyl of 1 to 5 carbon atoms and alkoxy of 1 to 5 carbon atoms, R1 and R2 are individually selected from the group consisting of hydrogen, halogen, alkyl and alkoxy of 1 to 8 carbon atoms,s cyclohexyl, -NO2 and phenoxy, R3 is selected from the group consisting of alkoxy and alkylthio of 1 to 8 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having a remarkable anxiolytic activity and a hypnotic activity and their preparation.
Patent MA-38819-A1 (MA)
Title: Dispositif de transmission, système de transmission et procédé de commutation de chemin
Inventor: KAGESHIMA HIDEO
IPC: H04J14/02
Filed: 2014-04-07
Abstract: La présente invention porte sur un dispositif de transmission avec lequel il est possible de résoudre le problème selon lequel la taille et le coût d'un dispositif de communication augmentent. Des unités de surveillance de lumière (331a et 331b) sont fournies en correspondance avec chaque chemin parmi de multiples chemins qui émettent un signal multiplexé en longueur d'onde, de multiples signaux de longueur d'onde optiques ayant des longueurs d'onde différentes étant multiplexés, et les unités de surveillance de lumière détectant le niveau de lumière du signal multiplexé en longueur d'onde transmis dans le chemin correspondant, ou les signaux de longueur d'onde optiques inclus dans ce signal multiplexé en longueur d'onde. Une unité de commutation (332) sélectionne l'un quelconque des multiples chemins et délivre le signal multiplexé en longueur d'onde émis dans le chemin sélectionné, ou les signaux de longueur d'onde optiques inclus dans ce signal multiplexé en longueur d'onde, en tant que signal optique. Sur la base des niveaux de lumière détectés par les unités de surveillance de lumière (331a et 331b) et du signal optique délivré par l'unité de commutation (332), une unité de traitement de signal (333) détecte des obstructions survenant dans les chemins, et change le chemin sélectionné par l'unité de commutation (332) en fonction du résultat de détection.
Patent MA-54017-A1 (MA)
Title: Obtention de données à partir d'un produit particulaire mobile
Inventor: DU PLESSIS FRANCOIS EBERHARDT
IPC: G01N21/85
Filed: 2020-01-23
Abstract: Une structure de capteur (10) est utilisée pour obtenir des données à partir d'un flux mobile de matériau particulaire (11), comprenant une source de lumière (56) fournissant un faisceau de lumière focalisé (64) pour éclairer les particules (11) et un récepteur de lumière (54) recevant la lumière réfléchie par les particules éclairées (11) et transmettant la lumière à un capteur optique. La lumière en provenance des particules éclairées (11) dans une petite zone d'analyse (65) est analysée pendant des intervalles courts, de sorte que la lumière en provenance d'une seule particule soit analysée à la fois. La lumière en provenance d'un grand nombre de particules individuelles (11) est analysée séparément et un résultat d'analyse est calculé à partir de l'analyse de la lumière réfléchie par les multiples particules individuelles (11).
Patent MA-59489-A1 (MA)
Title: Système de stockage et de récupération d'énergie thermique
Inventor: MCCORMICK KENTWELL
IPC: F28F21/02
Filed: 2021-06-27
Abstract: L'invention concerne, dans certains aspects, un système de stockage thermique qui comprend un ou plusieurs trous d'interconnexion de transport de fluide qui contiennent un fluide caloporteur et qui sont disposés en couplage thermique avec une forme de graphite, par exemple, du graphite expansé. La forme de graphite est, à son tour, disposée en couplage thermique avec un matériau d'agrégat lié.
Patent UY-23470-A1 (UY)
Title: Metodo para la dosificacion de cantidad en los productos para barnizar y correspondiente maquina
Inventor: EDOARDO ROSSETTI
IPC: G01G19/38
Filed: 1992-01-07
Abstract: Método para la dosificación de cantidad de colorantes en los productos para barnizar y relativa máquina, que comprende el empleo de n bombas con correspondientes n electroválvulas de circulación para suministrar a un producto barnizante, no o mas n de colorantes colocados dentro de contenedores dotados de mezcladores correspondientes. Las n electroválvulas suministradoras del colorante al producto para barnizar, están accionadas por motor eléctrico único, de tipo "paso paso" controlado por microprocesador, para hacer suministrar, a cada una de las bombas, la gota de colorante. Esta constituida por un mueble con armazón (1) proyectada con tres compartimientos laterales superiores unidos de los contenedores (16) del colorante y uno central dotado en la parte anterior de plano (4) que se mueve en forma vertical por cilindro operador (6) articulado a la base: sobre dicho plano esta colocado un contenedor (2, 3) para el producto para barnizar controlado por fotocélula situado debajo de la corona de toberas (8) alimentadas por las electroválvulas (10) por medio de bombas (25); en el plano de base, en el centro, está colocado el motor único (26) del tipo "paso paso", dotado de dos semi árboles laterales (29) para accionar cada uno, por medio de poleas dentadas y correspondientes correas. (ver Fig. 1)
Patent UY-23778-A1 (UY)
Title: Polipropileno de elevada resistencia a la fusion, procedimiento continuo para su produccion y articulo moldeado
Inventor: OSVALDO LUIZ PASSOS CONI JUNIOR
IPC: C08L23/12
Filed: 1994-05-13
Abstract: Propileno de elevada resistencia a la fusión de distribución de peso molecular amplia o bimodal, el cual imparte al producto, características reológicas tales como poder conformarse en máquinas normalmente utilizadas para resinas tales como el poliestireno. También se describen los artículos moldeados producidos a partir del propileno de la invención, al igual que un proceso continuo para producir el polipropileno de elevada resistencia a la fusión el cual se obtiene en presencia de sistema catalizado por tipo Ziegler-Natta, utilizando por lo menos dos recipientes de polimerización conectados en serie, llevándose a cabo el control del peso molecular mediante la adición de cantidades discretas de un regulador del peso molecular, tal como el hidrógeno, a por lo menos uno de los distintos recipientes de polimerización, para obtener en el primer recipiente de polimerización una parte de peso molecular superior y en los siguientes recipientes de polimerización, partes del polímero de peso molecular inferior, por medio de lo cual el polímero total exhibe una distribución de peso molecular amplia o bimodal, la cual le imparte al producto propiedades reológicas interesantes.
Patent UY-26416-A1 (UY)
Title: Compuestos
Inventor: FALLERY ANDREW
IPC: A61K31/16
Filed: 2000-10-25
Abstract: Un compuesto de la fórmula (I): donde: R es isopropilo; n es O; R1 es naftilmetilo; R2 es t-butilo; y R3 es metilo; es útil en el tratamiento de trastornos mediados por s-CD23.
Patent UY-27348-A1 (UY)
Title: Imidazotriazinas
Inventor: BAUSER DR MARCUS
Filed: 2002-06-21
Abstract: La invencinn se refiere a nuevas imidazotriazinas, a procedimientos para se preparacinn y a su uso para la preparacinn de medicamentos para el tratamiento y/o la profilaxis de enfermedades neurodegenerativas, especialmente de la enfermedad de parkinson.
Patent UY-28822-A1 (UY)
Title: Antagonistas de cgrp seleccionados, procedimiento para su preparación asi como su uso como medicamento
Inventor: RUDOLF KLAUS
Filed: 2005-03-28
Abstract: Objeto de la presente invención son los antagonistas de CGRP de l fórmula general en la que A,X, D, E, G, M, Q y R1 a R2 están definidos como en la reivindicación 1, sus tautómeros, sus diastereoisómeros, sus enantiómeros, sus hidratos, sus mezclas y sus sales, así como los hidratos de las sales, en particular sus sales fisiológicamente compatibles con ácidos o bases inogánicos u orgánicos, medicamentos que contienen estos compuestos, su uso y un procedimiento para su preparación.